Orion Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Orion Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,100	Closed	-$139K	–	562
2025 Q2	$139K	Hold	1,100	–	–	0.05%	154
2025 Q1	$141K	Sell	1,100 -200	-15%	-$27.1K	0.06%	152
2024 Q4	$172K	Buy	+1,300	New	+$183K	0.08%	130
2024 Q3	–	Sell	-1,300	Closed	-$178K	–	275
2024 Q2	$178K	Hold	1,300	–	–	0.09%	123
2024 Q1	$178K	Hold	1,300	–	–	0.09%	132
2023 Q4	$177K	Hold	1,300	–	–	0.1%	135
2023 Q3	$159K	Buy	+1,300	New	+$165K	0.1%	133
2023 Q2	–	Sell	-1,300	Closed	-$168K	–	277
2023 Q1	$168K	Hold	1,300	–	–	0.11%	127
2022 Q4	$171K	Hold	1,300	–	–	0.13%	122
2022 Q3	$152K	Hold	1,300	–	–	0.12%	124
2022 Q2	$153K	Hold	1,300	–	–	0.12%	117
2022 Q1	$169K	Hold	1,300	–	–	0.1%	128
2021 Q4	$198K	Hold	1,300	–	–	0.11%	119
2021 Q3	$210K	Hold	1,300	–	–	0.13%	108
2021 Q2	$213K	Hold	1,300	–	–	0.13%	105
2021 Q1	$196K	Hold	1,300	–	–	0.14%	102
2020 Q4	$151K	Buy	+1,300	New	+$186K	0.11%	100

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Orion Capital Management's IBB Position: Q3 2025 in Review

Orion Capital Management sold out of iShares Biotechnology ETF (IBB) in Q3 2025, closing a stake of 1,100 shares — an estimated $139K sold.

Orion Capital Management first reported a position in IBB in Q4 2020 and held it in 17 quarters. The position peaked at $213K in Q2 2021. 803 funds tracked by Wall St. Rank hold IBB as of Q3 2025.

Orion Capital Management reported no remaining iShares Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
Orion Capital Management sold 1,100 iShares Biotechnology ETF shares in Q3 2025, an estimated $139K.
Orion Capital Management first reported a position in iShares Biotechnology ETF in Q4 2020 and held it in 17 quarters.
Orion Capital Management's iShares Biotechnology ETF position peaked at $213K in Q2 2021.
803 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.

Based on Orion Capital Management's 13F filing for Q3 2025, filed 31 Oct 2025.